CLINICAL_TRIALS
trial_result
· 2018-07-17
Clinical Trial Update: Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer [Phase 2]
Summary
Phase 2 trial update of Provenge (sipuleucel-T) with or without pTVG-HP DNA booster vaccine in prostate cancer completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-17